PZZA vs SRPT · P/E 44, rev $2.06B vs rev $1.90B
Papa John's International Inc (PZZA) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Papa John's International Inc (PZZA) is a restaurants company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported PZZA revenue for 2024-12-29 was $2.06B. Net income was $84.2M. Revenue was down 3.6% from 2023-12-31 to 2024-12-29. PZZA currently screens at market cap $1.20B and trailing P/E 43.9.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
PZZA currently screens at market cap $1.20B and trailing P/E 43.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the PZZA and SRPT stock pages for the full models.
Not investment advice.